Document is current
Any future updates will be listed below
-
Authors
García-Tejedor, Amparo https://orcid.org/0000-0003-3398-0570
Guevara-Peralta, Rodrigo
Martinez-Garcia, Jose Manuel
Corbalán, Shiana
Agüero, Mauricio
Gomez-Romero, Maria
Cararach, Marta
Castellarnau, Marta
Rodríguez, Mariví
Lou-Mercadé, Ana Cristina
Costa, Laura
Rodríguez, Maria Jose
Huguet, Eva
Carreras, Manuel
Castel-Segui, Ana Belen
Font-Roig, Maria
Royo, Susana
Sarasa, Nuria
Candas, Beatriz
Perez-Carton, Samuel
Ortega, Carlos
Pla, Maria Jesus
Ponce, Jordi
-
Funding
Funding for this research was provided by:
Fundació Institució dels Centres de Recerca de Catalunya
- License Information
-
More Information
Article History
Received: 22 August 2025
Accepted: 23 September 2025
First Online: 4 November 2025
Declarations
:
: Roche Diagnostics International Ltd provided the antimüllerian hormone determination kits. Amparo García-Tejedor receives congress support from Italfarmaco SA and Corza medical for the endometriosis curse organisation and speaking in 2024; Ana C Lou from Gedeon and Theramex SA, Marivi Rodriguez also from MERCK SA. Susana Royo receives master funding support from SERONO SA. The authors alone are responsible for the content and writing of the paper. The preliminary results of this study were presented as an oral presentation at the XVI International Course of Gynecologic Surgery in 2019 in Barcelona, Spain, and in the form of an abstract at the 6th European Congress on Endometriosis in Bordeaux, France from June 15 to 17th, 2022.
: This study was approved by the Institutional Review Board of our hospital on February 8, 2018 (reference PR031/18).
